Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Blood plasma water content refers to the percentage of water in blood plasma, which normally ranges from about 90% to 93% depending on the source[1][2][3][5][7][8][10]. Blood plasma is the liquid, cell-free component of blood and makes up approximately 55% of total blood volume. It contains water, proteins (albumin, globulins, fibrinogen), electrolytes, nutrients, hormones, and metabolic wastes. The high water content is crucial for dissolving and transporting these molecules throughout the body, maintaining proper blood pressure and osmotic balance, enabling normal organ function, and assisting in waste elimination. Abnormal plasma water content can result from dehydration, fluid overload, altered protein/lipid concentration, or disease and may impact laboratory test results, especially sodium measurement[3]. The term "blood plasma water content" is a physiological measurement rather than a druggable target and is not classified as a molecule, receptor, enzyme, transporter, or protein. Any use as a target is incorrect and unrelated to therapeutic targeting in molecular pharmacology.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Blood plasma water content.